Wangzhi Li
Stock Analyst at Ladenburg Thalmann
(2.77)
# 1,988
Out of 5,012 analysts
3
Total ratings
66.67%
Success rate
27.26%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Wangzhi Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRYS Krystal Biotech | Initiates: Buy | $23 | $183.02 | -87.43% | 1 | Oct 18, 2017 | |
| LPTX Leap Therapeutics | Initiates: Buy | $180 | $0.63 | +28,635.63% | 1 | Mar 7, 2017 | |
| CLRB Cellectar Biosciences | Initiates: Buy | $8,100 | $5.13 | +157,794.74% | 1 | Dec 21, 2016 |
Krystal Biotech
Oct 18, 2017
Initiates: Buy
Price Target: $23
Current: $183.02
Upside: -87.43%
Leap Therapeutics
Mar 7, 2017
Initiates: Buy
Price Target: $180
Current: $0.63
Upside: +28,635.63%
Cellectar Biosciences
Dec 21, 2016
Initiates: Buy
Price Target: $8,100
Current: $5.13
Upside: +157,794.74%